Three patients who underwent transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. Images courtesy of JACC: Cardiovascular Interventions and Maznyczka, et al.
Calcified debris can sometimes lead to stent frame issues that cause a patient's TAVR valve to expand asymmetrically. Few studies have explored the potential impact of valve asymmetry—until now.
Boston Scientific's INGEVITY+ pacing leads were originally approved by the FDA back in 2019. They can now be used for LBBAP, a new alternative to biventricular pacing.
The 59-year-old cardiologist was known for both his clinical knowledge and his warm personality. He practiced with the same city hospital for nearly three decades.
The newly approved device comes in at 160 cm. Like the shorter LumiGuide device from Philips, it was designed to deliver real-time 3D visualization with light instead of X-rays.
Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.
Intravascular ultrasound (IVUS) is a catheter-based imaging technology that allows physicians to visualize blood vessels from the inside out. Image courtesy of Philips.
Which modality should care teams choose for PCI guidance? While there's an argument to be made for choosing IVUS over OCT, some specialists think the two treatment options are close to equal in terms of patient outcomes.
The HyperVue system uses both DeepOCT and near infrared spectroscopy (NIRS) imaging to help guide stent placement during interventional cardiology procedures.
The funds, including a significant investment from Johnson & Johnson, are expected to go toward expanding access to the company's HyperVue Imaging System and exploring new features.